Live Breaking News & Updates on Green Lifesciences

Stay updated with breaking news from Green lifesciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

The Ongoing Investigation of GLSI-100 Continues in the Flamingo-01 Study for HER2/Neu+ Breast Cancer

The ongoing Flamingo-01 trial continues to investigate GLSI-100 in HER2/neu-positive breast cancer following various holds. ....

San Antonio , United States , Baylor College Of Medicine , Mothaffarf Rimawi , Danl Duncan , Snehals Patel , Department Of Medicine , Steering Committee , Danl Duncan Comprehensive Cancer Center , Greenwich Lifesciences Inc , Greenwich Lifesciences , Data Safety Monitoring Board , Antonio Breast Cancer Symposium , Baylor College , Green Lifesciences , Lifesciences Provides Update , Flamingo 01 Trial , Glsi 100 , Er2 Neu Positive Breast Cancer , Her2 Neu Peptide Agent ,